SCHEMBL8327055

SCHEMBL8327055

O=C(N[C@H]1CCCN(c2ccc(I)cc2)C1=O)OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.49
CASP1 P29466 2/20 0.46
FPR2 P25090 2/20 0.45
FPR1 P21462 1/20 0.45
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
CTSK P43235 1/20 0.44
PREP P48147 2/20 0.43
NAAA Q02083 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8326106 0.87 CASP3 (0.47) CASP3CASP1FPR2FPR1ALDH1A1
SCHEMBL4480037 0.85 CASP3 (0.45) CASP3CASP1FPR2FPR1ALDH1A1
SCHEMBL13887434 0.85 CASP3 (0.45) CASP3CASP1FPR2FPR1ALDH1A1
SCHEMBL4487001 0.84 FPR2 (0.53) CASP3CASP1FPR2FPR1
SCHEMBL4338889 0.83 CCR1 (0.48) CASP3FPR2FPR1ALDH1A1GAA
SCHEMBL14601912 0.82 F10 (0.43) CASP3CASP1FPR2FPR1CTSL
SCHEMBL4472817 0.82 F10 (0.43) CASP3CASP1FPR2FPR1CTSL
SCHEMBL4489323 0.82 FPR2 (0.55) CASP3FPR2FPR1
SCHEMBL5179660 0.80 CTSL (0.51) CASP3FPR2FPR1ALDH1A1GAA
SCHEMBL13043811 0.80 CASP3 (0.53) CASP3CASP1ALDH1A1GAACTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7157470-B2 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-01-02 US disclosed
US-7157470-B2 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-01-02 US disclosed
WO-2004041776-A2 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-05-21 WO disclosed